Skip to Content


In the US, Crizotinib (crizotinib systemic) is a member of the drug class multikinase inhibitors and is used to treat Non-Small Cell Lung Cancer.

US matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Category

Antineoplastic agent: Tyrosine kinase inhibitor

Chemical Name

3-[(1R)-1-(2,6-dichloro-3-fluorophenyl)etoxy]-5-[1-(piperidin-4-yl)-1H-pyrazol-4-yl]pyridin-2-amine (WHO)

Foreign Names

  • Crizotinibum (Latin)
  • Crizotinib (German)
  • Crizotinib (French)
  • Crizotinib (Spanish)

Generic Names

  • Crizotinib (OS: USAN, JAN, BAN)
  • PF-02341066 (IS)
  • UNII-53AH36668S (IS)

Brand Names

  • Xalkori
    Laboratorio Pfizer de Chile, Chile; PF Prism, United States; Pfizer, Argentina; Pfizer, Australia; Pfizer, Bosnia & Herzegowina; Pfizer, Belgium; Pfizer, Brazil; Pfizer, Canada; Pfizer, Cyprus; Pfizer, Czech Republic; Pfizer, Denmark; Pfizer, Estonia; Pfizer, Spain; Pfizer, Finland; Pfizer, France; Pfizer, United Kingdom; Pfizer, Greece; Pfizer, Hong Kong; Pfizer, Croatia (Hrvatska); Pfizer, Indonesia; Pfizer, Ireland; Pfizer, South Korea; Pfizer, Lithuania; Pfizer, Latvia; Pfizer, Macedonia; Pfizer, Malaysia; Pfizer, Netherlands; Pfizer, Norway; Pfizer, New Zealand; Pfizer, Peru; Pfizer, Poland; Pfizer, Portugal; Pfizer, Sweden; Pfizer, Singapore; Pfizer, Slovenia; Pfizer, Slovakia; Pfizer, Thailand; Pfizer, Turkey; Pfizer H.C.P., Serbia; Pfizer Japan, Japan; Pfizer Limited, Iceland; Pfizer Limited, Romania
  • Xalkori 200 mg
    Pfizer, Hungary
  • Xalkori 200mg
    Pfizer, Austria; Pfizer, Switzerland; Pfizer, Germany; Pfizer, Israel; Pfizer, Luxembourg; Pfizer, Oman
  • Xalkori 250 mg
    Pfizer, Hungary
  • Xalkori 250mg
    Abacus, Austria; Haemato Pharm, Austria; Pfizer, Austria; Pfizer, Switzerland; Pfizer, Germany; Pfizer, Israel; Pfizer, Luxembourg; Pfizer, Oman


BANBritish Approved Name
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.